Compounds > benzoxazoles
Page last updated: 2024-08-21

benzoxazoles and rosiglitazone

benzoxazoles has been researched along with rosiglitazone in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akatsuka, H; Arakawa, K; Homma, K; Iijima, I; Inamasu, M; Kawanami, S; Matsumoto, M; Okumura, K; Ozeki, M; Saiga, Y; Watanabe, A; Yasuda, K1
Buckle, DR; Cantello, BC; Chapman, H; Clapham, JC; Coyle, PJ; Haigh, D; Hindley, RM; Holder, JC; Kallender, H; Latter, AJ; Lawrie, KW; Mossakowska, D; Murphy, GJ; Roxbee Cox, L; Smith, SA; Young, PW1
Ishida, Y; Ito, M; Kakutani, M; Matsushita, M; Nishiu, J; Shibata, T; Shindo, M1
Aschi, M; Besker, N; Crestani, M; Fracchiolla, G; Gilardi, F; Laghezza, A; Lavecchia, A; Loiodice, F; Mazza, F; Mitro, N; Montanari, R; Novellino, E; Pochetti, G; Re, N; Scotti, E; Tortorella, P1

Other Studies

4 other study(ies) available for benzoxazoles and rosiglitazone

ArticleYear
Novel benzoxazole 2,4-thiazolidinediones as potent hypoglycemic agents. Synthesis and structure-activity relationships.
    Chemical & pharmaceutical bulletin, 1997, Volume: 45, Issue:12

    Topics: Animals; Benzopyrans; Benzoxazoles; Chromans; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hypoglycemic Agents; Male; Mice; Obesity; Pioglitazone; Rosiglitazone; Structure-Activity Relationship; Thiazoles; Thiazolidinediones; Troglitazone

1997
Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gamma.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 284, Issue:2

    Topics: 3T3 Cells; Adipocytes; Animals; Benzoxazoles; Female; Humans; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Phenylpropionates; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Recombinant Proteins; Rosiglitazone; Structure-Activity Relationship; Thiazoles; Thiazolidinediones; Transcription Factors

1998
JTP-426467 acts as a selective antagonist for peroxisome proliferator-activated receptor gamma in vitro and in vivo.
    Diabetes, obesity & metabolism, 2006, Volume: 8, Issue:5

    Topics: Adipocytes; Adipogenesis; Animals; Anti-Obesity Agents; Benzoxazoles; Blood Glucose; Cell Differentiation; Cells, Cultured; Dose-Response Relationship, Drug; Gene Expression Regulation; Genes, Reporter; HeLa Cells; Humans; Hypoglycemic Agents; Leptin; Male; Mice; Obesity; PPAR gamma; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Weight Gain

2006
Structural insight into peroxisome proliferator-activated receptor gamma binding of two ureidofibrate-like enantiomers by molecular dynamics, cofactor interaction analysis, and site-directed mutagenesis.
    Journal of medicinal chemistry, 2010, Jun-10, Volume: 53, Issue:11

    Topics: Benzoxazoles; Butyrates; Co-Repressor Proteins; Humans; Molecular Dynamics Simulation; Mutagenesis, Site-Directed; PPAR gamma; Promoter Regions, Genetic; Protein Binding; Protein Conformation; Rosiglitazone; Stereoisomerism; Structure-Activity Relationship; Thiazolidinediones

2010